tenk.fyi

Jasper Therapeutics, Inc.

JSPRNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$71.3M

10.6% YoY

EPS

$-4.89

20.9% YoY

Cash

$71.6M

17.6% YoY

FY 2024 · As of 2024-12-31